Intervention with bacterial adhesion by multivalent carbohydrates

Medicinal Research Reviews

Volumn 27, Issue 6, 2007, Pages 796-816

  Pieters, Roland J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Bacterial adhesion; Carbohydrate; Glycodendrimers

Indexed keywords

ADHESIN; CELL ADHESION MOLECULE; DENDRIMER; GLYCODENDRIMER; GLYCOPOLYMER; LECTIN; LECTIN A; LECTIN B; MANNOSE; MANNOSIDE; MEMBRANE PROTEIN; N ACETYL BETA 1 GALACTOSAMINE; N ACETYLGALACTOSAMINE; POLYAMIDOAMINE; POLYAMIDOAMINE 8; POLYMER; PROTEIN FIMH; RIGID1,3; RIGID11,4; UNCLASSIFIED DRUG;

BACTERIAL INFECTION; BACTERIUM ADHERENCE; BACTERIUM DETECTION; BINDING AFFINITY; BINDING SITE; BLADDER DISEASE; FIMBRIA; NONHUMAN; PROTEIN CARBOHYDRATE INTERACTION; REVIEW; STRUCTURE ACTIVITY RELATION;

ADHESINS, BACTERIAL; ANIMALS; BACTERIA; BACTERIAL ADHESION; CARBOHYDRATES; HUMANS;

EID: 35649003866     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/med.20089     Document Type: Review

References (129)

1. Levy SB. Antibiotic resistance-the problem intensifies. Adv Drug Deliv Rev 2005;57:1446-1450.
2. Wolfson W. Holding back the tide of antibiotic resistance. Chem Biol 2006;13:1-3.
3. Zopf D, Roth S. Oligosaccharide anti-infective agents. Lancet 1996;347:1017-1021.
4. Ofek I, Hasty DL, Sharon N. Anti-adhesion therapy of bacterial diseases: Prospects and problems. FEMS Immunol Med Microbiol 2003;38:181-191.
5. Bavington C, Page C. Stopping bacterial adhesion: A novel approach to treating infections. Respiration 2005;72:335-344.
6. Kunz C, Rudloff S, Baier W, Klein N, Strobel S. Oligosaccharides in human milk: Structural, functional, and metabolic aspects. Annu Rev Nutr 2000;20:699-722.
7. Johnson KF. Synthesis of oligosaccharides by bacterial enzymes. Glycoconj J 1999;16:141-146.
8. Sachdeva G, Kumar K, Jain P, Ramachandran S. SPAAN: A software program for prediction of adhesins and adhesin-like proteins using neural networks. Bioinformatics 2005;21:483-491.
9. (a) Moch T, Hoschutzky H, Hacker J, Kroncke KD, Jann K. Isolation and characterization of the alpha-sialyl-beta-2,3-galactosyl-specific adhesin from fimbriated Escherichia coli. Proc Natl Acad Sci USA 1987;84:3462-3466.
10. (b) Khan AS, Muhldorfer I, Demuth V, Wallner U, Korhonen TK, Hacker J. Functional analysis of the minor subunits of S fimbrial adhesion (SfaI) in pathogenic Escherichia coli. Mol Gen Genet 2000;263:96-105.
11. Khan AS, Kniep B, Oelschlaeger TA, Van Die I, Korhonen T, Hacker J. Receptor structure for F1C fimbriae of uropathogenic Escherichia coli. Infect Immun 2000;68:3541-3547.
12. Khan AS, Hacker J. Glycolipid receptors of F1C fimbrial adhesin of uropathogenic Escherichia coli. Adv Exp Med Biol 2000;485:213-217.
13. (a) Hanson MS, Brinton CC Jr. Identification and characterization of E. coli type-1 pilus tip adhesion protein. Nature 1988;332:265-268.
14. (b) Jones CH, Pinkner JS, Roth R, Heuser J, Nicholes AV, Abraham SN. Proc Natl Acad Sci USA 1995;92:2081-2085.
15. Jones CH, Pinkner JS, Roth R, Heuser J, Nicholes AV, Abraham SN, Hultgren SJ. FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae. Proc Natl Acad Sci USA 1995;92:2081-2085.
16. Ponniah S, Endres RO, Hasty DL, Abraham SN. Fragmentation of Escherichia coli type 1 fimbriae exposes cryptic D-mannose-binding sites. J Bacteriol 1991;173:4195-4202.
17. Krogfelt KA, Bergmans H, Klemm P Direct evidence that the FimH protein is the mannose-specific adhesin of Eschericia coli type 1 fimbriae. Infect Immun 1990;58:1995-1998.
18. Saulino ET, Bullitt E, Hultgren SJ. Snapshots of usher-mediated protein secretion and ordered pilus assembly. Proc Natl Acad Sci USA 2000;97:9240-9245.
19. Choudhury D, Thompson A, Stojanoff V, Langermann S, Pinkner J, Hultgren SJ, Knight SD. X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli. Science 1999;285(5430):1061-1066.
20. Hung CS, Bouckaert J, Hung D, Pinkner J, Widberg C, DeFusco A, Auguste CG, Strouse R, Langermann S, Waksman G, Hultgren SJ. Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection. Mol Microbiol 2002;44:903-915.
21. Duncan MJ, Mann EL, Cohen MS, Ofek I, Sharon N, Abraham SN. The distinct binding specificities exhibited by enterobacterial type 1 fimbriae their fimbrial shafts. J Biol Chem 2005;280:37707-37716.
22. Dodson KW, Pinkner JS, Rose T, Magnusson G, Hultgren SJ, Waksman G. Structural basis of the interaction of the pyelonephritic E. coli adhesin to its human kidney receptor. Cell 2001;105:733-743.
23. Sung MA, Fleming K, Chen HA, Matthews S. The solution structure of PapGII from uropathogenic Escherichia coli and its recognition of glycolipid receptors. EMBO Rep 2001;2:621-627.
24. Krivan HC, Roberts DD, Ginsburg V. Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids. Proc Natl Acad Sci USA 1988;85:6157-6161.
25. Thomas RJ, Brooks TJ. Oligosaccharide receptor mimics inhibit Legionella pneumophila attachment to human respiratory epithelial cells. Microb Pathog 2004;36:83-92.
26. Thomas R, Brooks T. Common oligosaccharide moieties inhibit the adherence of typical and atypical respiratory pathogens. J Med Microbiol 2004;53:833-840.
27. Imundo L, Barasch J, Prince A, Al-Awqati Q. Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. Proc Natl Acad Sci USA 1995;92:3019-3023.
28. Sheth HB, Lee KK, Wong WY, Srivastava G, Hindsgaul O, Hodges RS, Paranchych W, Irvin RT. The pili of Pseudomonas aeruginosa strains PAK and PAO bind specifically to the carbohydrate sequence beta GalNAc(1-4)βGal found in glycosphingolipids asialo-GM1 and asialo-GM2. Mol Microbiol 1994;11:715-723.
29. Keizer DW, Slupsky CM, Kalisiak M, Campbell AP, Crump MP, Sastry PA, Hazes B, Irvin RT, Sykes BD. Structure of a pilin monomer from Pseudomonas aeruginosa: Implications for the assembly of pili. J Biol Chem 2001;276:24186-24193.
30. Audette GF, Irvin RT, Hazes B. Crystallographic analysis of the Pseudomonas aeruginosa strain K122-4 monomelic pilin reveals a conserved receptor-binding architecture. Biochemistry 2004;43:11427-11435.
31. Giltner CL, van Schaik EJ, Audette GF, Kao D, Hodges RS, Hassett DJ, Irvin RT. The Pseudomonas aeruginosa type IV pilin receptor binding domain functions as an adhesin for both biotic and abiotic surfaces. Mol Microbiol 2006;59:1083-1096.
32. van Schaik EJ, Giltner CL, Audette GF, Keizer DW, Bautista DL, Slupsky CM, Sykes BD, Irvin RT. DNA binding: A novel function of Pseudomonas aeruginosa type IV pili. J Bacteriol 2005;187:1455-1464.
33. Mitchell E, Houles C, Sudakevitz D, Wimmerova M, Gautier C, Perez S, Wu AM, Gilboa-Garber N, Imberty A. Structural basis for oligosaccharide-mediated adhesion of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients. Nat Struct Biol 2002;9:918-921.
34. Cioci G, Mitchell EP, Gautier C, Wimmerova M, Sudakevitz D, Perez S, Gilboa-Garber N, Imberty A. Structural basis of calcium and galactose recognition by the lectin PA-IL of Pseudomonas aeruginosa. FEBS Lett 2003;555:297-301.
35. Imberty A, Wimmerova M, Mitchell EP, Gilboa-Garber N. Structures of the lectins from Pseudomonas aeruginosa: Insight into the molecular basis for host glycan recognition. Microbes Infect 2004;6:221-228.
36. Tielker D, Hacker S, Loris R, Strathmann M, Wingender J, Wilhelm S, Rosenau F, Jaeger KE. Pseudomonas aeruginosa lectin LecB is located in the outer membrane and is involved in biofilm formation. Microbiology 2005;151:1313-1323.
37. Pieters RJ. Inhibition and detection of galectins. ChemBioChem 2006;7:721-728.
38. Bryan R, Feldman M, Jawetz SC, Rajan S, DiMango E, Tang HB, Scheffler L, Speert DP, Prince A. The effects of aerosolized dextran in a mouse model of Pseudomonas aeruginosa pulmonary infection. J Infect Dis 1999;179:1449-1458.
39. Zinger-Yosovich K, Sudakevitz D, Imberty A, Garber NC, Gilboa-Garber N. Production and properties of the native Chromobacterium violaceum fucose-binding lectin (CV-IIL) compared to homologous lectins of Pseudomonas aeruginosa (PA-IIL) and Ralstonia solanacearum (RS-IIL). Microbiology 2006;152:457-463.
40. Sudakevitz D, Kostlanova N, Blatman-Jan G, Mitchell EP, Lerrer B, Wimmerova M, Katcoff DJ, Imberty A, Gilboa-Garber N. A new Ralstonia solanacearum high-affinity mannose-binding lectin RS-IIL structurally resembling the Pseudomonas aeruginosa fucose-specific lectin PA-IIL. Mol Microbiol 2004;52:691-700.
41. Arends JP, Zanen HC. Meningitis caused by Streptococcus suis in humans. Rev Infect Dis 1988;10:131-137.
42. Staats JJ, Feder I, Okwumabua O, Chengappa MM. Streptococcus suis: Past and present. Vet Res Commun 1997;21:381-407.
43. Haataja S, Tikkanen K, Liukkonen J, Francois-Gerard C, Finne J. Characterization of a novel bacterial adhesion specificity of Streptococcus suis recognizing blood group P receptor oligosaccharides. J Biol Chem 1993;268:4311-4317.
44. Haataja S, Tikkanen K, Nilsson U, Magnusson G, Karlsson KA, Finne J. Oligosaccharide-receptor interaction of the Galα1-4Gal binding adhesin of Streptococcus suis. Combining site architecture and characterization of two variant adhesin specificities. J Biol Chem 1994;269:27466-27472.
45. Haataja S, Zhang Z, Tikkanen K, Magnusson G, Finne J. Determination of the cell adhesion specificity of Streptococcus suis with the complete set of monodeoxy analogues of globotriose. Glycoconj J 1999;16(1):67-71.
46. Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET, Berg DE, Covacci A, Engstrand L, Boren T. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998;279:373-377.
47. Mahdavi J, Sonden B, Hurtig M, Olfat FO, Forsberg L, Roche N, Angstrom J, Larsson T, Teneberg S, Karlsson KA, Altraja S, Wadstrom T, Kersulyte D, Berg DE, Dubois A, Petersson C, Magnusson KE, Norberg T, Lindh F, Lundskog BB, Arnqvist A, Hammarstrom L, Boren T. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 2002;297:573-578.
48. Bennett HJ, Roberts IS. Identification of a new sialic acid-binding protein in Helicobacter pylori. FEMS Immunol Med Microbiol 2005;44:163-169.
49. Miller-Podraza H, Johansson P, Angstrom J, Larsson T, Longard M, Karlsson KA. Studies on gangliosides with affinity for Helicobacter pylori: Binding to natural and chemically modified structures. Glycobiology 2004;14:205-217.
50. Roche N, Angstrom J, Hurtig M, Larsson T, Boren T, Teneberg S. Helicobacter pylori and complex gangliosides. Infect Immun 2004;72:1519-1529.
51. Miller-Podraza H, Lanne B, Angstrom J, Teneberg S, Milh MA, Jovall PA, Karlsson H, Karlsson KA. Novel binding epitope for Helicobacter pylori found in neolacto carbohydrate chains: Structure and cross-binding properties. J Biol Chem 2005;280:19695-19703.
52. Mysore JV, Wigginton T, Simon PM, Zopf D, Heman-Ackah LM, Dubois A. Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound. Gastroenterology 1999;117:1316-1325.
53. Gustafsson A, Hultberg A, Sjostrom R, Kacskovics I, Breimer ME, Boren T, Hammarstrom L, Holgersson J. Carbohydrate-dependent inhibition of Helicobacter pylori colonization using porcine milk. Glycobiology 2006;16:1-10.
54. Firon N, Ofek I, Sharon N. Interaction of mannose-containing oligosaccharides with the fimbrial lectin of Escherichia coli. Biochem Biophys Res Commun 1982;105:1426-1432.
55. Firon N, Ashkenazi S, Mirelman D, Ofek I, Sharon N. Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cells. Infect Immun 1987;55:472-476.
56. Lindhorst TK, Kotter S, Kubisch J, Krallmann-Wenzel U, Ehlers S, Kren V. Effect of p-substitution of aryl alpha-D-mannosides on inhibiting mannose-sensitive adhesion of Escherichia coli - Syntheses and testing. Eur J Org Chem 1998;1669-1674.
57. Bouckaert J, Berglund J, Schembri M, De Genst E, Cools L, Wuhrer M, Hung CS, Pinkner J, Slattegard R, Zavialov A, Choudhury D, Langermann S, Hultgren SJ, Wyns L, Klemm P, Oscarson S, Knight SD, De Greve H. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Mol Microbiol 2005;55:441-455.
58. Sokurenko EV, Courtney HS, Maslow J, Siitonen A, Hasty DL. Quantitative differences in adhesiveness of Type 1 fimbriated Escherichia coli due to structural differences in fimH genes. J Bacteriol 1995;177:3680-3686.
59. Qian X, Metallo SJ, Choi IS, Wu H, Liang MN, Whitesides GM. Arrays of self-assembled monolayers for studying inhibition of bacterial adhesion. Anal Chem 2002;74:1805-1810.
60. Kihlberg J, Magnusson G. Use of carbohydrates and peptides in studies of adhesion of pathogenic bacteria and in efforts to generate carbohydrate-specific T cells. Pure Appl Chem 1996;68:2119-2128.
61. Kihlberg J, Hultgren SJ, Normark S, Magnusson G. Probing of the combining site of the PapG adhesin of uropathogenic Escherichia coli bacteria by synthetic analogs of galabiose. J Am Chem Soc 1989;111:6364-6368.
62. Ohlsson J, Jass J, Uhlin BE, Kihlberg J, Nilsson UJ. Discovery of potent inhibitors of PapG adhesins from uropathogenic Escherichia coli through synthesis and evaluation of galabiose derivatives. ChemBioChem 2002;3:772-779.
63. Larsson A, Ohlsson J, Dodson KW, Hultgren SJ, Nilsson U, Kihlberg J. Quantitative studies of the binding of the class II PapG adhesin from uropathogenic Escherichia coli to oligosaccharides. Bioorg Med Chem 2003;11:2255-2261.
64. Ohlsson J, Larsson A, Haataja S, Alajaaski J, Stenlund P, Pinkner JS, Hultgren SJ, Finne J, Kihlberg J, Nilsson UJ. Structure-activity relationships of galabioside derivatives as inhibitors of E. coli and S. suis adhesins: Nanomolar inhibitors of S. suis adhesins. Org Biomol Chem 2005;3:886-900.
65. Schweizer F, Jiao H, Hindsgaul O, Wong WY, Irvin RT. Interaction between the pili of Pseudomonas aeruginosa PAK and its carbohydrate receptor β-D-GalNAc(1 → 4) β-D-Gal analogs. Can J Microbiol 1998;44:307-311.
66. Sabin C, Mitchell EP, Pokorna M, Gautier C, Utille JR Wimmerova M, Imberty A. Binding of different monosaccharides by lectin PA-IIL from Pseudomonas aeruginosa: Thermodynamics data correlated with X-ray structures. FEBS Lett 2006;580:982-987.
67. Perret S, Sabin C, Dumon C, Pokorna M, Gautier C, Galanina O, Ilia S, Bovin N, Nicaise M, Desmadril M, Gilboa-Garber N, Wimmerova M, Mitchell EP, Imberty A. Structural basis for the interaction between human milk oligosaccharides and the bacterial lectin PA-IIL of Pseudomonas aeruginosa. Biochem J 2005;389:325-332.
68. Lanne B, Ciopraga J, Bergstrom J, Motas C, Karlsson KA. Binding of the galactose-specific Pseudomonas aeruginosa lectin, PA-I, to glycosphingolipids and other glycoconjugates. Glycoconj J 1994;11:292-298.
69. Kirkeby S, Moe D. Analyses of Pseudomonas aeruginosa lectin binding to alpha-galactosylated glycans. Curr Microbiol 2005;50:309-313.
70. Boteva RN, Bogoeva VP, Stoitsova SR. PA-I lectin from Pseudomonas aeruginosa binds acyl homoserine lactones. Biochim Biophys Acta 2005;1747:143-149.
71. (a) Aronson M, Medalia O, Schori L, Mirelman D, Sharon N, Ofek I. Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl β-D- mannopyranoside. J Infect Dis 1979;139:329-332.
72. (b) Eden CS, Freter R, Hagberg L, Hull R, Hull S, Leffler H, Schoolnik G. Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue. Nature 1982;298:560-562.
73. Liang MN, Smith SP, Metallo SJ, Choi IS, Prentiss M, Whitesides GM. Measuring the forces involved in polyvalent adhesion of uropathogenic Escherichia coli to mannose-presenting surfaces. Proc Natl Acad Sci USA 2000;97:13092-13096.
74. Pethe K, Alonso S, Biet F, Delogu G, Brennan MJ, Locht C, Menozzi FD. The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature 2001;412:190-194.
75. Dupres V, Menozzi FD, Locht C, Clare BH, Abbott NL, Cuenot S, Bompard C, Raze D, Dufrene YF. Nanoscale mapping and functional analysis of individual adhesins on living bacteria. Nat Methods 2005;2:515-520.
76. Mammen M, Chio S-K, Whitesides GM. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed 1998;37:2754-2794.
77. Lundquist JJ, Toone EJ. The cluster glycoside effect. Chem Rev 2002;102:555-578.
78. Lindhorst TK. Artificial multivalent sugar ligands to understand and manipulate carbohydrate-protein interactions. Top Curr Chem 2002;218:201-235.
79. Lee RT, Lee YC. Affinity enhancement by multivalent lectin - Carbohydrate interaction. Glycoconj J 2002; 17:543-551.
80. Turnbull WB, Stoddart JF. Design and synthesis of glycodendrimers. Rev Mol Biotechnol 2002;90:231-255.
81. Cloninger MJ. Biological applications of dendrimers. Curr Opin Chem Biol 2002;6:742-748.
82. Roy R. A decade of glycodendrimer chemistry. Trends Glycosci Glycotechnol 2003;15:291-310.
83. Pieters RJ. Interference with lectin binding and bacterial adhesion by multivalent carbohydrates and peptidic carbohydrate mimics. Trends Glycosci and Glycotechnol 2004;16; 243-254.
84. Rao JH, Lahiri J, Weis RM, Whitesides GM. Design, synthesis, and characterization of a high-affinity trivalent system derived from vancomycin and L-Lys-D-Ala-D-Ala. J Am Chem Soc 2000;112:2698-2710.
85. (a) Kitov PI, Sadowska JM, Mulvey G, Armstrong GD, Ling H, Pannu NS, Read RJ, Bundle DR. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands. Nature 2000;403:669-672.
86. (b) Fan EK, Zhang ZS, Minke WE, Hou Z, Verlinde CLMJ, Hol WGJ. High-affinity pentavalent ligands of Escherichia coli heat-labile enterotoxin by modular structure-based design. J Am Chem Soc 2000;122:2663-2664.
87. (c) Zhang ZS, Merritt EA, Ahn M, Roach C, Hou Z, Verlinde CLMJ, Hol WGJ, Fan E. Solution and crystallographic studies of branched multivalent ligands that inhibit the receptor-binding of cholera toxin. J Am Chem Soc 2002;124:12991-12998.
88. (d) Merritt EA, Zhang Z, Pickens JC, Ahn M, Hol WGJ, Fan E. Characterization and Crystal Structure of a High-Affinity Pentavalent Receptor-Binding Inhibitor for Cholera Toxin and E. coli Heat-Labile Enterotoxin. J Am Chem Soc 2002;124;8818-8824.
89. (e) Gargano JM, Ngo T, Kim JY, Acheson DWK, Lees WJ. Multivalent inhibition of AB(5) toxins. J Am Chem Soc 2001;123:12909-12910.
90. (f) Arosio D, Vrasidas I, Valentini P, Liskamp RM, Pieters RJ, Bernardi A. Synthesis and cholera toxin binding properties of multivalent GM1 mimics. Org Biomol Chem 2004;2:2113-2124.
91. Zhang Z, Pickens JC, Hol WG, Fan E. Solution- and solid-phase syntheses of guanidine-bridged, water-soluble linkers for multivalent ligand design. Org Lett 2004;6:1377-1380.
92. (a) Kotter S, Krallmann-Wenzel U, Ehlers S, Lindhorst TK. Multivalent ligands for the mannose-specific lectin on type 1 fimbriae of Escherichia coli: Syntheses and testing of trivalent alpha-D-mannoside clusters. J Chem Soc Perk Trans 1 1998;14:2193-2200.
93. (b) Lindhorst TK, Kieburg C, Krallmann-Wenzel U. Inhibition of the type 1 fimbriae-mediated adhesion of Escherichia coli to erythrocytes by multiantennary alpha-mannosyl clusters: The effect of multivalency. Glycoconj J 1998;15:605-613.
94. (c) Lindhorst TK, Kotter S, Kubisch J, Krallmann-Wenzel U, Ehlers S, Kren V. Effect of p-substitution of aryl alpha-D-mannosides on inhibiting mannose-sensitive adhesion of Escherichia coli - Syntheses and testing. Eur J Org Chem 1998;1669-1674.
95. (d) Lindhorst TK, Kotter S, Krallmann-Wenzel U, Ehlers S. Trivalent alpha-D-mannoside clusters as inhibitors of type-1 fimbriae-mediated adhesion of Escherichia coli: Structural variation and biotinylation. J Chem Soc Perk Trans 1 2001;1:823-831.
96. (e) Lindhorst TK, Dubber M, Krallmann-Wenzel U, Ehlers S. Cluster mannosides as inhibitors of type 1 fimbriae-mediated adhesion of Escherichia coli: Pentaerythritol derivatives as scaffolds. Eur J Org Chem 2000;2027-2034.
97. (f) Boysen MMK, Eisner K, Sperling O, Lindhorst TK. Glycerol and glycerol glycol glycodendrimers. Eur J Org Chem 2003;4376-4386.
98. Nagahori N, Lee RT, Nishimura S, Page D, Roy R, Lee YC. Inhibition of adhesion of type 1 fimbriated Escherichia coli to highly mannosylated ligands. ChemBioChem 2002;3:836-844.
99. Appeldoorn CCM, Joosten JAF, el Maate FA, Dobrindt U, Hacker J, Liskamp RMJ, Khan AS, Pieters RJ. Novel multivalent mannose compounds and their inhibition of the adhesion of type 1 fimbriated uropathogenic E. coli. Tet Asym 2005;16(2):361-372.
100. Autar R, Liskamp RM, Pieters RJ. A facile synthesis of the GalNAcα1 → 4Gal target sequence of respiratory pathogens. Carbohydr Res 2005;340:2436-2442.
101. Autar R, Khan AS, Schad M, Hacker J, Liskamp RM, Pieters RJ. Adhesion inhibition of F1C-fimbriated Escherichia coli and Pseudomonas aeruginosa PAK and PAO by multivalent carbohydrate ligands. ChemBioChem 2003;4:1317-1325.
102. Simon PM, Goode PL, Mobasseri A, Zopf D. Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligosaccharides. Infect Immun 1997;65:750-757.
103. Barthelson R, Mobasseri A, Zopf D, Simon P. Adherence of Streptococcus pneumoniae to respiratory epithelial cells is inhibited by sialylated oligosaccharides. Infect Immun 1998;66:1439-1444.
104. Idanpaan-Heikkila I, Simon PM, Zopf D, Vullo T, Cahill P, Sokol K, Tuomanen E. Oligosaccharides interfere with the establishment and progression of experimental pneumococcal pneumonia. J Infect Dis 1997;176:704-712.
105. Hansen HC, Haataja S, Finne J, Magnusson G. Di-, Tri-, and tetravalent dendritic galabiosides that inhibit hemagglutination by Streptococcus suis at nanomolar concentration. J Am Chem Soc 1997;119;6974-6979. (b)
106. Joosten JA, Loimaranta V, Appeldoorn CC, Haataja S, El Maate FA, Liskamp RM, Finne J, Pieters RJ. Inhibition of Streptococcus suis adhesion by dendritic galabiose compounds at low nanomolar concentration. J Med Chem 2004;47:6499-6508.
107. Andre S, Pieters RJ, Vrasidas I, Kaltner H, Kuwabara I, Liu FT, Liskamp RM, Gabius HJ. Wedgelike glycodendrimers as inhibitors of binding of mammalian galectins to glycoproteins, lactose maxiclusters, and cell surface glycoconjugates. ChemBioChem 2001;2:822-830.
108. Dimick SM, Powell SC, McMahon SA, Moothoo DN, Naismith JH, Toone EJ. On the meaning of affinity: Cluster glycoside effects and concanavalin A. J Am Chem Soc 1999;121:10286-10296.
109. Wehner MR, Koch SR, Kindinger L, Nelson N, Cowan MM. Asparaginase inhibition of adhesion of type 1-fimbriated and P-fimbriated Escherichia coli to epithelial cell receptors. Appl Microbiol Biotechnol 2004;66:71-73.
110. Svensson M, Platt F, Frendeus B, Butters T, Dwek R, Svanborg C. Carbohydrate receptor depletion as an antimicrobial strategy for prevention of urinary tract infection. J Infect Dis 2001;183:S70-S73.
111. Hedenstrom M, Emtenas H, Pemberton N, Aberg V, Hultgren SJ, Pinkner JS, Tegman V, Almqvist F, Sethson I, Kihlberg J. NMR studies of interactions between periplasmic chaperones from uropathogenic E. coli and pilicides that interfere with chaperone function and pilus assembly. Org Biomol Chem 2005;3:4193-4200.
112. Svensson A, Larsson A, Emtenas H, Hedenstrom M, Fex T, Hultgren SJ, Pinkner JS, Almqvist F, Kihlberg J. Design and evaluation of pilicides: Potential novel antibacterial agents directed against uropathogenic Escherichia coli. ChemBioChem 2001;2:915-918.
113. Larsson A, Johansson SM, Pinkner JS, Hultgren SJ, Almqvist F, Kihlberg J, Linusson A. Multivariate design, synthesis, and biological evaluation of peptide inhibitors of FimC/FimH protein-protein interactions in uropathogenic Escherichia coli. J Med Chem 2005;48:935-945.
114. Rendle PM, Seger A, Rodrigues J, Oldham NJ, Bott RR, Jones JB, Cowan MM, Davis BG. Glycodendriproteins: A synthetic glycoprotein mimic enzyme with branched sugar-display potently inhibits bacterial aggregation. J Am Chem Soc 2004;126:4750-4751.
115. Roos V, Ulett GC, Schembri MA, Klemm P. The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine. Infect Immun 2006;74:615-624.
116. Klemm P, Roos V, Ulett GC, Svanborg C, Schembri MA. Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: The taming of a pathogen infect. Immun 2006;74:781-785.
117. Wizemann TM, Adamou JE, Langermann S. Adhesins as targets for vaccine development. Emerg Infect Dis 1999;5:395-403.
118. Langermann S, Palaszynski S, Barnhart M, Auguste G, Pinkner JS, Burlein J, Barren P, Koenig S, Leath S, Jones CH, Hultgren SJ. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 1997;276:607-611.
119. Disney MD, Seeberger PH. The use of carbohydrate microarrays to study carbohydrate-cell interactions and to detect pathogens. Chem Biol 2004;11:1701-1707.
120. Hsu KL, Pilobello KT, Mahal LK. Analyzing the dynamic bacterial glycome with a lectin microarray approach. Nat Chem Biol 2006;2:153-157.
121. Disney MD, Zheng J, Swager TM, Seeberger PH. Detection of bacteria with carbohydrate-functionalized fluorescent polymers. J Am Chem Soc 2004;126:13343-13346.
122. Ukkonen P, Varis K, Jernfors M, Herva E, Jokinen J, Ruokokoski E, Zopf D, Kilpi T. Treatment of acute otitis media with an antiadhesive oligosaccharide: A randomised, double-blind, placebo-controlled trial. Lancet 2000;356:1398-1402.
123. Mulvey GL, Marcato P, Kitov PI, Sadowska J, Bundle DR, Armstrong GD. Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands. J Infect Dis 2003;187:640-649.
124. Nishikawa K, Matsuoka K, Kita E, Okabe N, Mizuguchi M, Hino K, Miyazawa S, Yamasaki C, Aoki J, Takashima S, Yamakawa Y, Nishijima M, Terunuma D, Kuzuhara H, Natori Y. A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157: H7. Proc Natl Acad Sci USA 2002;99:7669-7674.
125. Plante OJ, Palmacci ER, Seeberger PH. Automated synthesis of polysaccharides. Methods Enzymol 2003;369:235-248.
126. Drouillard S, Driguez H, Samain E. Large-scale synthesis of h-antigen oligosaccharides by expressing Helicobacter pylori alpha1,2- fucosyltransferase in metabolically engineered Escherichia coli cells. Angew Chem Int Ed Engl 2006;45:1778-1780.
127. Zhang Z, Ollmann IR, Ye XS, Wischnat R, Baasov T, Wong CH. Programmable one-pot oligosaccharide synthesis. J Am Chem Soc 1999;121:734-753.
128. Joosten JAF, Tholen NTH, Ait El Maate F, Brouwer AJ, van Esse GW, Rijkers DTS, Liskamp RMJ, Pieters RJ. High yielding microwave assisted synthesis of triazole-linked glycodendrimers via copper catalyzed [3 + 2] cycloaddition. Eur J Org Chem 2005;3182-3185.
129. Gao Y, Eguchi A, Kakehi K, Lee YC. Synthesis and molecular recognition of carbohydrate-centered multivalent glycoclusters by a plant lectin RCA120. Bioorg Med Chem 2005;13:6151-6157.